chr4-144118734-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NM_002099.8(GYPA):c.251C>T(p.Ala84Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000146 in 1,436,478 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A84P) has been classified as Likely benign.
Frequency
Consequence
NM_002099.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GYPA | NM_002099.8 | c.251C>T | p.Ala84Val | missense_variant | 4/7 | ENST00000641688.3 | NP_002090.4 | |
LOC105377460 | XR_002959803.2 | n.5270+3505G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GYPA | ENST00000641688.3 | c.251C>T | p.Ala84Val | missense_variant | 4/7 | NM_002099.8 | ENSP00000493142 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152120Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000717 AC: 18AN: 250944Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135620
GnomAD4 exome AF: 0.0000146 AC: 21AN: 1436478Hom.: 0 Cov.: 26 AF XY: 0.0000140 AC XY: 10AN XY: 716498
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000394 AC: 6AN: 152120Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74294
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 17, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at